Cancer patients given fluids live longer

January 10, 2018, University of Surrey

Dying cancer patients given fluids will generally live longer, a new study led by researchers from Royal Surrey County Hospital NHS Foundation Trust and the University of Surrey has found.

End-of-life receiving assisted hydration had a 26 per cent greater survival, which meant that they lived for on average one-and-a-half more days, compared to those who were not receiving such treatment.

Over a year more than 200 , who were in the last week of their life, took part in the study at four cancer centres and eight hospices across the country.

All of the participants, aged between 28 and 98 years, were unable to maintain sufficient intake on their own and as a result received it either intravenously, administered directly into a vein, or subcutaneously, delivered under the skin.

They were assessed every four hours, with the teams collecting data on clinical problems, interventions and overall survival.

As well as increasing life by an average of one-and-a-half days, patients' receiving fluids were also found to have good symptom control, and to suffer from minimal side effects.

A further study is now planned to continue to evaluate the role that providing fluids plays in end of life care.

Andrew Davies, a consultant in Palliative Medicine at Royal Surrey, said: "The provision of clinically assisted hydration at the end-of-life is one of the most contentious issues in medicine.

"The results of this study are certainly interesting, but a larger study is needed to confirm the role of clinically assisted hydration at the end of life".

"For some patients and their families living an extra day or so may be extremely important, as it can give them an opportunity to say their goodbyes, have family arrive from abroad, write a will or even get married.

"Nevertheless, for other patients, living an extra day or so may be the worst thing possible."

Dr. Agnieszka Michael, Medical Director of the Clinical Trials Unit at the University of Surrey, said: "Hydration of dying patients in palliative care delivers the gift of time however this is not a gift that all patients and their families desire.

"Hydration plays a key role in delaying the dying process, why this is remains unknown. We will be exploring this in further studies and the results from this will help improve quality in end of care."

Explore further: Italy OKs living wills amid long-running euthanasia debate

More information: A cluster randomised feasibility trial of clinically assisted hydration in cancer patients in the last days of life. Journal of Palliative Medicine. DOI: 10.1177/0269216317741572

Related Stories

Italy OKs living wills amid long-running euthanasia debate

December 14, 2017
Italy's Senate gave final approval Thursday to a law allowing Italians to write living wills and refuse artificial nutrition and hydration, the latest step in the Roman Catholic nation's long-running and agonizing debate ...

Dying patients who received palliative care visited the ER less

February 21, 2017
Community-based palliative care—care delivered at home, not the hospital—was associated with a 50 percent reduction in emergency department visits for patients in their last year of life. The results of an Australian ...

Parenteral hydration no benefit for cancer care in hospices

November 28, 2012
(HealthDay)—For patients with advanced cancer in hospices, providing parenteral saline (1 liter per day) does not improve symptoms associated with dehydration, quality of life, or overall survival compared with placebo, ...

Most nursing home residents eligible for palliative care but lack access

November 21, 2017
Nearly 70 percent of nursing home residents are eligible for palliative care, but do not receive any corresponding support to provide relief from their symptoms and improve their quality of life, according to a study by researchers ...

Choosing to die at home does not hasten death for patients with terminal cancer

March 28, 2016
A large study from Japan found that cancer patients who died at home tended to live longer than those who died in hospitals. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings ...

Research examines benefits of palliative care in heart failure treatment

October 18, 2017
Patients living with heart failure receive palliative care significantly less often than patients with other illnesses, including cancer, despite evidence that such care improves symptom management and quality of life.

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.